Markets:

Overview

News

Currencies

International

Treasuries

Merus N.V. - Common Shares (NQ:MRUS)

92.44 -4.48 (-4.62%)

Streaming Delayed Price Updated: 11:31 AM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merus N.V. - Common Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Merus to Participate in a Fireside Chat at the Jefferies Healthcare Conference 2023

May 31, 2023

From Merus N.V.

Via GlobeNewswire

7 Stocks That Wall Street Analysts Are Loving in May ↗

May 21, 2023

Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love.

Via InvestorPlace

Where Merus Stands With Analysts ↗

May 18, 2023

Via Benzinga

Recap: Merus Q1 Earnings ↗

May 04, 2023

Via Benzinga

Merus Announces Financial Results for the First Quarter 2023 and Provides Business Update

May 04, 2023

From Merus N.V.

Via GlobeNewswire

Analyst Boosts Merus Price Target As AACR Updates Meaningfully De-Risk Its Head & Cancer Therapy ↗

April 18, 2023

Via Benzinga

The Latest Analyst Ratings for Merus ↗

April 05, 2023

Via Benzinga

4 Analysts Have This to Say About Merus ↗

March 01, 2023

Via Benzinga

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 18, 2023

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...

Via Benzinga

Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday ↗

April 18, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Merus Earnings Perspective: Return On Capital Employed ↗

November 24, 2022

Via Benzinga

5 Analysts Have This to Say About Merus ↗

November 16, 2022

Via Benzinga

Merus’ Petosemtamab Interim Data Demonstrates Clinically Meaningful Activity in Previously Treated Head and Neck Squamous Cell Carcinoma (HNSCC)

April 17, 2023

From Merus N.V.

Via GlobeNewswire

Merus' Petosemtamab Abstract Hits Upside Scenario For Overall Response Rate, Duration Of Response: Analyst ↗

April 14, 2023

Via Benzinga

Merus Announces Publication of an Abstract on Petosemtamab in Advanced Gastric/Esophageal Adenocarcinoma for Presentation at the AACR Annual Meeting 2023

April 14, 2023

From Merus N.V.

Via GlobeNewswire

Merus Announces Publication of an Abstract on Petosemtamab Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma for Plenary Session Oral Presentation at the AACR Annual Meeting 2023 and Provides a Program and Regulatory Update

April 14, 2023

From Merus N.V.

Via GlobeNewswire

What To Expect When Merus Presents Petosemtamab Data Update At AACR ↗

April 06, 2023

Via Benzinga

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

Via InvestorPlace

Merus Announces Publication of an Abstract on Preclinical Mechanism of Action of MCLA-129 Selected for Poster Presentation at the AACR Annual Meeting 2023

March 14, 2023

Poster presentation: Tuesday, April 18, 2023, 1:30-5:30 p.m. ET

From Merus N.V.

Via GlobeNewswire

Merus Announces Petosemtamab in Previously Treated Head and Neck Squamous Cell Carcinoma Abstract Selected for Plenary Session Oral Presentation at the AACR Annual Meeting 2023

March 14, 2023

From Merus N.V.

Via GlobeNewswire

Merus Announces Financial Results for the Fourth Quarter and Full Year 2022 and Provides Business Update

February 28, 2023

From Merus N.V.

Via GlobeNewswire

MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday ↗

February 09, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 09, 2023

Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.

Via Benzinga

Merus to Participate in Upcoming Investor Conferences

February 01, 2023

From Merus N.V.

Via GlobeNewswire

CORRECTING and REPLACING --Merus Provides 2023 Outlook

January 09, 2023

From Merus N.V.

Via GlobeNewswire

Merus Provides 2023 Outlook

January 08, 2023

From Merus N.V.

Via GlobeNewswire

Merus to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference

November 09, 2022

From Merus N.V.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday ↗

November 04, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.

Via Benzinga

Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session ↗

November 03, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.